Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Current Assets (2020 - 2023)

Historic Current Assets for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $270.5 million.

  • Terns Pharmaceuticals' Current Assets rose 4194.36% to $270.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $270.5 million, marking a year-over-year increase of 4194.36%. This contributed to the annual value of $285.2 million for FY2022, which is 7084.11% up from last year.
  • According to the latest figures from Q3 2023, Terns Pharmaceuticals' Current Assets is $270.5 million, which was up 4194.36% from $288.3 million recorded in Q2 2023.
  • In the past 5 years, Terns Pharmaceuticals' Current Assets registered a high of $299.7 million during Q1 2023, and its lowest value of $90.9 million during Q4 2020.
  • Its 4-year average for Current Assets is $204.4 million, with a median of $188.7 million in 2021.
  • Per our database at Business Quant, Terns Pharmaceuticals' Current Assets plummeted by 2369.05% in 2022 and then skyrocketed by 10218.3% in 2023.
  • Over the past 4 years, Terns Pharmaceuticals' Current Assets (Quarter) stood at $90.9 million in 2020, then soared by 83.7% to $166.9 million in 2021, then skyrocketed by 70.84% to $285.2 million in 2022, then fell by 5.17% to $270.5 million in 2023.
  • Its Current Assets stands at $270.5 million for Q3 2023, versus $288.3 million for Q2 2023 and $299.7 million for Q1 2023.